SCHEMBL13289633

SCHEMBL13289633

Bc1cnn2c(NCc3cccnc3)cc(C3CCN(Cc4ccc5c(c4)OCO5)CC3)nc12

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GSK3B P49841 7/20 0.56
▸ FAAH O00519 2/20 0.46
▸ MCHR1 Q99705 1/20 0.46
▸ ACHE P22303 1/20 0.45
▸ BACE1 P56817 1/20 0.45
▸ KDM4E B2RXH2 4/20 0.44
▸ ALDH1A1 P00352 4/20 0.44
▸ GAA P10253 1/20 0.44
▸ MAPT P10636 1/20 0.44
▸ TDP1 Q9NUW8 2/20 0.44
▸ CHEK1 O14757 1/20 0.44
▸ CLK4 Q9HAZ1 4/20 0.43
▸ CLK1 P49759 3/20 0.43
▸ DYRK1A Q13627 3/20 0.43
▸ CDK2 P24941 1/20 0.43
▸ CLK2 P49760 1/20 0.43
▸ CLK3 P49761 1/20 0.43
▸ DYRK1B Q9Y463 1/20 0.43
▸ UBE2M P61081 1/20 0.42
▸ DCUN1D1 Q96GG9 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14607118 0.92 GSK3B (0.53) GSK3BFAAHMCHR1ACHEBACE1
SCHEMBL13122043 0.91 GSK3B (0.70) GSK3BCDK2
SCHEMBL12954525 0.88 GSK3B (0.61) GSK3BCHEK1CDK2
SCHEMBL14418882 0.88 GSK3B (0.54) GSK3BCHEK1CDK2
SCHEMBL13288850 0.88 GSK3B (0.52) GSK3BFAAHKDM4EALDH1A1GAA
SCHEMBL13289787 0.87 GSK3B (0.59) GSK3BCHEK1CDK2
SCHEMBL13289352 0.87 GSK3B (0.58) GSK3BCHEK1CDK2
SCHEMBL14043403 0.86 GSK3B (0.60) GSK3BCHEK1CDK2
SCHEMBL14050829 0.86 GSK3B (0.61) GSK3BCHEK1CDK2
SCHEMBL13289421 0.85 GSK3B (0.58) GSK3BCHEK1CDK2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2194058-A1 Pyrazolopyrimidines suitable for the treatment of cancer diseases SCHERING CORPORATION (US) 2010-06-09 — — EP disclosed
Send feedback